X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1405) 1405
Publication (128) 128
Book Chapter (38) 38
Book Review (35) 35
Book / eBook (12) 12
Conference Proceeding (6) 6
Dissertation (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1171) 1171
index medicus (535) 535
animals (495) 495
hematology (336) 336
male (311) 311
female (290) 290
peripheral vascular disease (258) 258
factor xii - metabolism (227) 227
coagulation (213) 213
blood coagulation (200) 200
biochemistry & molecular biology (186) 186
factor xiia - metabolism (179) 179
middle aged (174) 174
adult (173) 173
thrombin (173) 173
thrombosis (167) 167
risk factors (154) 154
kinetics (153) 153
activation (138) 138
mice (137) 137
blood-coagulation (133) 133
tissue factor (130) 130
thrombin - metabolism (128) 128
molecular-weight kininogen (124) 124
blood coagulation - drug effects (122) 122
fibrinolysis (121) 121
amino acid sequence (119) 119
factor xii (117) 117
immunology (114) 114
aged (113) 113
inflammation (112) 112
anticoagulants (109) 109
plasma (109) 109
proteins (103) 103
analysis (102) 102
molecular sequence data (102) 102
factor xiia (99) 99
time factors (99) 99
factor-xii (98) 98
hemostasis (96) 96
hageman-factor (94) 94
kallikreins - metabolism (93) 93
enzyme activation (92) 92
factor xi - metabolism (92) 92
kallikrein (91) 91
molecular weight (89) 89
prekallikrein - metabolism (89) 89
research (88) 88
protein binding (87) 87
blood coagulation - physiology (84) 84
heparin (83) 83
article (81) 81
contact activation (78) 78
prekallikrein (77) 77
binding sites (73) 73
blood (70) 70
blood platelets - metabolism (70) 70
anticoagulants - pharmacology (67) 67
bradykinin (67) 67
physiological aspects (66) 66
rats (66) 66
cell biology (65) 65
in-vivo (65) 65
medicine & public health (64) 64
platelets (64) 64
thrombosis - blood (64) 64
blood coagulation factors - metabolism (63) 63
cattle (59) 59
models, biological (59) 59
pharmacology & pharmacy (59) 59
myocardial-infarction (58) 58
multidisciplinary sciences (57) 57
signal transduction (57) 57
contact system (56) 56
thromboplastin - metabolism (56) 56
dose-response relationship, drug (55) 55
endothelial-cells (55) 55
medicine (55) 55
disease models, animal (54) 54
enzymes (54) 54
fibrin (54) 54
partial thromboplastin time (54) 54
medicine, research & experimental (53) 53
anticoagulants - therapeutic use (52) 52
blood coagulation tests (51) 51
cardiac & cardiovascular systems (51) 51
plasma kallikrein (51) 51
thrombin generation (51) 51
proteases (50) 50
cells, cultured (49) 49
health aspects (49) 49
protein conformation (49) 49
coagulation-factor-xii (48) 48
expression (48) 48
human hageman-factor (48) 48
human-plasma (48) 48
heparin - pharmacology (47) 47
research article (47) 47
surgery (47) 47
thrombosis - etiology (47) 47
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1416) 1416
French (10) 10
German (2) 2
Italian (2) 2
Russian (2) 2
Spanish (2) 2
Chinese (1) 1
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Circulation, ISSN 0009-7322, 2010, Volume 121, Issue 13, pp. 1510 - 1517
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2016, Volume 11, Issue 10, p. e0165493
The serpin C1 inhibitor (C1-INH) is the only regulator of classical complement activation as well as the major regulator of the contact system. Its importance... 
HEPARIN-BINDING | C1-ESTERASE INHIBITOR | PLASMA KALLIKREIN | DEXTRAN SULFATE | GLYCOSAMINOGLYCANS | HEREDITARY ANGIOEDEMA | MULTIDISCIPLINARY SCIENCES | COAGULATION | SERINE-PROTEASE | CLASSICAL PATHWAY | FACTOR XIA | Factor XIIa - metabolism | Complement Activation | Humans | Glucuronic Acid - metabolism | Structure-Activity Relationship | Glycosaminoglycans - chemistry | Alginates - metabolism | Heparitin Sulfate - metabolism | beta-Glucans - chemistry | Sulfates - chemistry | Dextran Sulfate - metabolism | Polysaccharides - chemistry | Complement C1 Inhibitor Protein - metabolism | Glucuronic Acid - chemistry | Dextran Sulfate - chemistry | Glycosaminoglycans - metabolism | Enzyme Assays | Hexuronic Acids - chemistry | Polysaccharides - metabolism | Complement C1 Inhibitor Protein - chemistry | beta-Glucans - metabolism | Factor XIIa - antagonists & inhibitors | Heparitin Sulfate - chemistry | Alginates - chemistry | Protein Binding | Kinetics | Hexuronic Acids - metabolism | Sulfates | Polysaccharides | Anticoagulants (Medicine) | Potentiation | Molecular structure | Handbooks | Activation | Complement | Biology | Structure-activity relationships | Glucan | Immunology | Ischemia | Inhibition | Angioedema | Pharmacology | Thrombosis | Glycan | Sulfation | Complement component C1 | Complement activation | Inhibitors | Coronary vessels | Sepsis | Chondroitin sulfate | Heparin | Binding sites | Pharmaceuticals
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, p. e0144940
Journal Article
PLOS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, p. e0146783
Background and Purpose Ischemic stroke provokes severe brain damage and remains a predominant disease in industrialized countries. The coagulation factor XII... 
ISCHEMIA-REPERFUSION INJURY | STROKE | SYSTEM | ACTIVATION | THROMBUS FORMATION | MULTIDISCIPLINARY SCIENCES | MICE | PROVIDES PROTECTION | DEFICITS | CONTACT PATHWAY | INFESTIN-4 | Factor XIIa - metabolism | Cricetulus | Insect Proteins - pharmacology | Recombinant Fusion Proteins - pharmacology | Recombinant Fusion Proteins - therapeutic use | Rats | Male | Serum Albumin, Human | Brain - drug effects | Serine Proteinase Inhibitors - therapeutic use | Serum Albumin - therapeutic use | Brain - blood supply | Rotarod Performance Test | Animals | Factor XIIa - antagonists & inhibitors | Reperfusion Injury - prevention & control | Serum Albumin - pharmacology | Brain - pathology | Insect Proteins - therapeutic use | Infarction, Middle Cerebral Artery - drug therapy | Drug Evaluation, Preclinical | Serine Proteinase Inhibitors - pharmacology | CHO Cells | Complications and side effects | Care and treatment | Ischemia | Patient outcomes | Physiological aspects | Brain damage | Research | Blood coagulation factors | Drug therapy | Occlusion | Brain | Blood coagulation | Traumatic brain injury | Prophylaxis | Coagulation | Coagulation factor XIIa | Activation | Carotid arteries | Immunology | Reperfusion | Cerebral blood flow | Rodents | Physiology | Edema | Anticoagulants | Stroke | Inflammation | Survival | Thrombosis | Blood clots | Neurological diseases | Coagulation factors | Injury prevention | Brain research | Inhibitors | Brain injury | Coagulation factor XII | Veins & arteries
Journal Article